Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Vpx is a small virion-associated adaptor protein encoded by viruses of the HIV-2/SIVsm lineage of primate lentiviruses that enables these viruses to transduce monocyte-derived cells. This probably reflects the ability of Vpx to overcome an as yet uncharacterized block to an early event in the virus life cycle in these cells, but the underlying mechanism has remained elusive. Using biochemical and proteomic approaches, we have found that Vpx protein of the pathogenic SIVmac 239 strain associates with a ternary protein complex comprising DDB1 and VprBP subunits of Cullin 4-based E3 ubiquitin ligase, and DDA1, which has been implicated in the regulation of E3 catalytic activity, and that Vpx participates in the Cullin 4 E3 complex comprising VprBP. We further demonstrate that the ability of SIVmac as well as HIV-2 Vpx to interact with VprBP and its associated Cullin 4 complex is required for efficient reverse transcription of SIVmac RNA genome in primary macrophages. Strikingly, macrophages in which VprBP levels are depleted by RNA interference resist SIVmac infection. Thus, our observations reveal that Vpx interacts with both catalytic and regulatory components of the ubiquitin proteasome system and demonstrate that these interactions are critical for Vpx ability to enable efficient SIVmac replication in primary macrophages. Furthermore, they identify VprBP/DCAF1 substrate receptor for Cullin 4 E3 ubiquitin ligase and its associated protein complex as immediate downstream effector of Vpx for this function. Together, our findings suggest a model in which Vpx usurps VprBP-associated Cullin 4 ubiquitin ligase to enable efficient reverse transcription and thereby overcome a block to lentivirus replication in monocyte-derived cells, and thus provide novel insights into the underlying molecular mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was previously reported that in myeloid cells transduced with HIV-2, Vpx prevents the inhibition of HIV-1 infection by associating with and hijacking a cellular E3 ubiquitin-protein ligase complex, including the proteins cullin 4 and DCAF1 [82,83].”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 1×
“To obtain further insight into the role of VprBP, we knocked down its expression in macrophages by RNA interference (RNAi, [25]).”
BackgroundEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“Tandem mass (MS/MS) spectra were interpreted using SEQUEST [37] against a database of 82242 sequences, consisting of hfa-tagged SIVmac Vpx, usual contaminants, and 40873 human proteins, as well as, to estimate false discovery rates, randomized amino acid sequences derived from each non-redundant protein entry.”
MethodFunction and regulation of cullin–RING ubiquitin ligases
Petroski, M. D., & Deshaies, R. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1547 · Cited by 2,148 · cited 2×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundTabb, D. L., McDonald, W. H., & Yates, J. R. (2002) · Journal of Proteome Research · doi:10.1021/pr015504q · Cited by 1,367 · cited 1×
“Peptide hits from multiple runs were compared using CONTRAST [38].”
MethodGroisman, R., Polanowska, J., Kuraoka, I., Sawada, J.-I., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K., & Nakatani, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00316-7 · Cited by 744 · cited 1×
“[23]).”
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739 · cited 1×
“The phenotype of Vpx-deficient virions is reminiscent of that resulting from a block to retrovirus replication imposed by tripartite motif protein 5α (TRIM5α) restriction factors. TRIM5α is a E3 ubiquitin ligase that inactivates the incoming virions, probably by deregulating their uncoating so rapidly that the late re…”
BackgroundJin, J., Arias, E. E., Chen, J., Harper, J. W., & Walter, J. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.010 · Cited by 632 · cited 1×
“). Cullin 4 is a scaffold protein that assembles a family of E3 ubiquitin ligase complexes. DDB1 is an obligatory subunit of all Cullin 4 E3's that bridges the catalytic cores organized on the Cullin 4 scaffold to a substrate-recruiting subunit, and VprBP/DCAF1 is a putative substrate adaptor for Cullin 4-based E3 ubi…”
BackgroundDCAFs, the Missing Link of the CUL4-DDB1 Ubiquitin Ligase
Lee, J., & Zhou, P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.001 · Cited by 460 · cited 1×
“substrate adaptor for Cullin 4-based E3 ubiquitin ligases ([15] reviewed in [16,17]).”
BackgroundPaxton, W., Connor, R. I., & Landau, N. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7229-7237.1993 · Cited by 371 · cited 1×
“Furthermore, the incoming virions probably contain at most only several hundred Vpx molecules, similar to Vpr, which also is virion recruited through its interaction with Gag p6 [6,30,31].”
BackgroundLe Rouzic, E., Belaïdouni, N., Estrabaud, E., Morel, M., Rain, J.-C., Transy, C., & Margottin-Goguet, F. (2007) · Cell Cycle · doi:10.4161/cc.6.2.3732 · Cited by 267
Cited by
Items 101–200 of 220
Accessories to the crime: Recent advances in HIV accessory protein biology
Gramberg, T., Sunseri, N., & Landau, N. R. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0006-z · Cited by 29
The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA
Dar, A. A., Sawada, K., Dybas, J. M., Moser, E. K., Lewis, E. L., Park, E., Fazelinia, H., Spruce, L. A., Ding, H., Seeholzer, S. H., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001041 · Cited by 28
“It is known to be targeted by HIV-1 and 2 viral proteins R and X (Vpr and Vpx), respectively [62,63].”
BackgroundPower, C., Hui, E., Vivithanaporn, P., Acharjee, S., & Polyak, M. J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9310-7 · Cited by 28
“ubiquitin ligase complex leads to the proteosomal degradation of the inhibitory factor, SAMHD1 (Laguette et al. 2011; Srivastava et al. 2008).”
BackgroundSIV Vpx Is Essential for Macrophage Infection but Not for Development of AIDS
Westmoreland, S. V., Converse, A. P., Hrecka, K., Hurley, M., Knight, H., Piatak, M., Lifson, J. D., Mansfield, K. G., Skowroński, J., & Desrosiers, R. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084463 · Cited by 27
PIM kinases facilitate lentiviral evasion from SAMHD1 restriction via Vpx phosphorylation
Miyakawa, K., Matsunaga, S., Yokoyama, M., Nomaguchi, M., Kimura, Y., Nishi, M., Kimura, H., Sato, H., Hirano, H., Tamura, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09867-7 · Cited by 27
Roles of Vpr and Vpx in modulating the virus-host cell relationship
Planelles, V., & Barker, E. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.002 · Cited by 26
“These studies show that depletion of DCAF1 via RNA interference (Sharova et al., 2008; Srivastava et al., 2008) or expression of a Vpx mutant, Q76A, devoid of DCAF1 binding (Srivastava et al., 2008) ablated the enhancement of infectivity by Vpx. Mol Aspects Med.”
BackgroundInfluentialShingai, M., Welbourn, S., Brenchley, J. M., Acharya, P., Miyagi, E., Plishka, R. J., Buckler-White, A. J., Kwong, P. D., Nishimura, Y., Strebel, K., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004928 · Cited by 26
“To ascertain whether a Vpx point mutant, specifically defective in recruiting DCAF1 and subsequently degrading SAMHD1[7,16 – 18], might possess similar properties, the X-Q76A Vpx mutant, carrying a 2-nucleotide substitution, was constructed (Fig 1A).”
HIV-1 Viral Protein R (VPR) and its Interactions with Host Cell
Li, G., Bukrinsky, M., & Zhao, Y. (2009) · Current HIV Research · doi:10.2174/157016209787581436 · Cited by 33
“Indeed, SIV vpx, which was derived from African green monkey vpr gene by an ancestral recombination event [21], has been shown to overcome an as yet unidentified block to SIV reverse transcription in macrophages [22,23].”
BackgroundRegulation of Viral Restriction by Post-Translational Modifications
Chamontin, C., Bossis, G., Nisole, S., Arhel, N. J., & Maarifi, G. (2021) · Viruses · doi:10.3390/v13112197 · Cited by 28
Yu, H., Usmani, S. M., Borch, A., Krämer, J., Stürzel, C., Khalid, M., Li, X., Krnavek, D., van der Ende, M. E., Osterhaus, A., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-27 · Cited by 27
“Several domains and residues previously described to be critical for Vpx function, such as the C-terminal stretch of seven proline residues that are critical for stable Vpx expression [33,34], as well as a Wx4Φx2Φx3AΦxH motif and residue Q76 involved in DCAF1 binding [35-37] were preserved in all HIV-2 Vpx alleles ana…”
BackgroundZhou, X., DeLucia, M., Hao, C., Hrecka, K., Monnie, C. M., Skowroński, J., & Ahn, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798801 · Cited by 25
“U2OS cells were transfected with siRNA targeting DCAF1, HLTF, or non-targeting scrambled siRNA (26,40) using Lipofectamine RNAiMAX according to the manufacturer’s instructions.”
MethodTailored HIV-1 Vectors for Genetic Modification of Primary Human Dendritic Cells and Monocytes
Durand, S., Nguyen, X.-N., Turpin, J., Cordeil, S., Nazaret, N., Croze, S., Mahieux, R., Lachuer, J., Legras‐Lachuer, C., & Cimarelli, A. (2012) · Journal of Virology · doi:10.1128/jvi.01459-12 · Cited by 26
SAMHD1 Restricts HIV-1 Replication and Regulates Interferon Production in Mouse Myeloid Cells
Zhang, R., Bloch, N., Nguyen, L. A., Kim, B., & Landau, N. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089558 · Cited by 27
“SAMHD1 is localized to the nucleus of the cell through a nuclear localization sequence located at amino acids 11–14 and its degradation is thought to occur in the nucleus through the activity of nuclear CRL4 [14–17].”
BackgroundEvidence for a Different Susceptibility of Primate Lentiviruses to Type I Interferons
Cordeil, S., Nguyen, X.-N., Berger, G., Durand, S., Ainouze, M., & Cimarelli, A. (2012) · Journal of Virology · doi:10.1128/jvi.02553-12 · Cited by 22
“ruses encode Vpx, a protein that has been shown to speed up reverse transcription (48, 62, 63).”
BackgroundMaudet, C., Bertrand, M., Rouzic, E. L., Lahouassa, H., Ayinde, D., Nisole, S., Goujon, C., Cimarelli, A., Margottin-Goguet, F., & Transy, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220780 · Cited by 26
Degradation of SAMHD1 by Vpx Is Independent of Uncoating
Jáuregui, P., Logue, E. C., Schultz, M. L., Fung, S., & Landau, N. R. (2015) · Journal of Virology · doi:10.1128/jvi.03575-14 · Cited by 23
“The CRL4 complex is composed of DDB1, RBX1, Cul4, and DCAF1, and it is believed that Vpx interacts directly with DCAF1 in the complex (14, 16, 17).”
BackgroundSubversion of Cell Cycle Regulatory Mechanisms by HIV
Rice, A. P., & Kimata, J. T. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.010 · Cited by 21
Yang, S., Shan, T., Zhou, Y., Jiang, Y., Tong, W., Liu, F., Wen, F., Zhang, Q., & Tong, G. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.07.024 · Cited by 22
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes
Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.159 · Cited by 21
“Vpx was initially known to physically interact with the Cullin4 E3 ubiquitin ligase complex via association with DCAF1 and DDB1 (damage-specific DNA binding protein1) (Sharova et al., 2008; Srivastava et al., 2008), suggesting that, similar to Vif and Vpu, Vpx targets a restriction factor for degradation.”
BackgroundBreaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives
Thippeshappa, R., Ruan, H., & Kimata, J. T. (2012) · Biology · doi:10.3390/biology1020134 · Cited by 20
“Vpx, which likely evolved as a result of duplication of the vpr gene [148], has been shown to interact with the DDB1-CUL4-DCAF1 E3 ubiquitin ligase complex and enhance HIV-1 infection of DCs, monocytes, and macrophages by causing proteasomal degradation of a putative restriction factor [144,149,150].”
BackgroundLandsberg, C. D., Megger, D. A., Hotter, D., Rückborn, M. U., Eilbrecht, M., Rashidi‐Alavijeh, J., Howe, S., Heinrichs, S., Sauter, D., Sitek, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02978 · Cited by 23
“Therefore, the Vpx mutant Q76A, known to lack the ability to interact with VprBP and DDB1 (32), was used to test the relevance of CRLs (Figure 6E).”
MethodGene Transduction in Human Monocyte-Derived Dendritic Cells Using Lentiviral Vectors
Satoh, T., & Manel, N. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-218-6_30 · Cited by 20
Self-citationHIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 (IRF5) and Inhibits Its Function
Cheng, X., & Ratner, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534321 · Cited by 20
“linked to its ability to enhance virus replication in dendritic cells and macrophages in tissue culture (21, 23, 24, 26, 38).”
BackgroundEvidence for Vpr-dependent HIV-1 Replication in Human CD4+CEM.NKR T-Cells
Zhou, T., Dang, Y., Baker, J. J., Zhou, J., & Zheng, Y. (2012) · Retrovirology · doi:10.1186/1742-4690-9-93 · Cited by 20
“Vpx also enhances viral nuclear import, but it promotes viral replication through DCAF1 by overcoming a restriction factor that blocks viral reverse transcription [29,30].”
Nucleotide embargo by SAMHD1: A strategy to block retroviral infection
Pauls, E., Ballana, E., & Esté, J. A. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.12.009 · Cited by 21
Cellular and Biochemical Mechanisms of the Retroviral Restriction Factor SAMHD1
Wu, L. J. (2013) · ISRN Biochemistry · doi:10.1155/2013/728392 · Cited by 19
“Further studies indicated that Vpx from SIV or HIV-2 can interact with the host protein DCAF1 in the CUL4A/DDB1 and E3 ubiquitin ligase complex [42, 43], indicating that Vpx may target a putative HIV-1 restriction factor for proteasomal degradation in myeloid cells through the E3 ubiquitin ligase complex (for reviews,…”
BackgroundThe role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest
Sharifi, H. J., Furuya, A. K. M., & de Noronha, C. M. C. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835049e0 · Cited by 21
Wei, W., Guo, H., Gao, Q., Markham, R. B., & Yu, X. (2013) · Journal of Virology · doi:10.1128/jvi.02866-13 · Cited by 20
“nally HA-tagged SAMHD1 N(110-626) and C(1-611) constructs were”
BackgroundGérard, F. C. A., Yang, R., Romani, B., Poisson, A. O., Belzile, J.-P., Rougeau, N., & Cohen, É. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089195 · Cited by 19
“Interestingly, Vpr and its paralog, Vpx, which is exclusively encoded by HIV-2 and several SIV lineages, are not the only viral proteins to usurp CRL4A E3 ligases [11,18,19].”
BackgroundHost Proteome Research in HIV Infection
Zhang, L., Zhang, X., Ma, Q., & Zhou, H. (2010) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(10)60001-0 · Cited by 19
Intertwined: SAMHD1 cellular functions, restriction, and viral evasion strategies
Majer, C., Schüssler, M., & König, R. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00593-x · Cited by 20
Functional region mapping of HIV-2 Vpx protein
Fujita, M., Otsuka, M., Nomaguchi, M., & Adachi, A. (2008) · Microbes and Infection · doi:10.1016/j.micinf.2008.08.005 · Cited by 18
“We and others have found that the Q76A mutation abolishes viral growth ability in MDMs [4,19], and the mutant is unable to bind to the E3 ligase complex [19].”
BackgroundInfluentialManipulation of the nucleotide pool in human, bacterial and plant immunity
Hochhauser, D., & Sorek, R. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01206-w · Cited by 21
SAMHD1: A Novel Antiviral Factor in Intrinsic Immunity
Chen, Z., Zhang, L., & Ying, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.81 · Cited by 18
Cellular Restriction Factors of Feline Immunodeficiency Virus
Zielonka, J., & Münk, C. (2011) · Viruses · doi:10.3390/v3101986 · Cited by 19
“In myeloid cells, Vpx mutants of HIV-2 and SIVmac show a post-entry block at reverse transcription or uncoating [115,123–125].”
HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome
Li, G., Elder, R. T., Dubrovsky, L., Liang, D., Pushkarsky, T., Chiu, K., Fan, T., Sire, J., Bukrinsky, M., & Zhao, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011371 · Cited by 19
“Several recent reports demonstrate that the activity of Vpx, also limited to macrophages, stimulates reverse transcription by counteracting a yet unidentified cellular restriction factor [11,55].”
BackgroundRevising the Role of Myeloid cells in HIV Pathogenesis
Aggarwal, A., McAllery, S., & Turville, S. G. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0149-1 · Cited by 16
Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2014) · Journal of Virology · doi:10.1128/jvi.00241-14 · Cited by 16
Positive selection in dNTPase SAMHD1 throughout mammalian evolution
Monit, C., Morris, E. R., Ruis, C., Szafran, B., Thiltgen, G., Tsai, M.-H., Mitchison, N. A., Bishop, K. N., Stoye, J. P., Taylor, I. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908755116 · Cited by 18
HIV-2 Vpx neutralizes host restriction factor SAMHD1 to promote viral pathogenesis
Mohamed, A., Bakir, T. F., Al-Hawel, H., Alsharif, I., Bakheet, R., Kouser, L., Murugaiah, V., & Al-Mozaini, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-00415-2 · Cited by 16
Binding to DCAF1 distinguishes TASOR and SAMHD1 degradation by HIV-2 Vpx
Martin, M. M., Matkovic, R., Larrous, P., Morel, M., Lasserre, A., Vauthier, V., & Margottin-Goguet, F. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009609 · Cited by 14
Hakata, Y., Miyazawa, M., & Landau, N. R. (2014) · Virology Journal · doi:10.1186/1743-422x-11-108 · Cited by 13
“Mutation of the conserved glutamine Q76 residue in this motif, which is corresponding to the Q65 residue of Vpr, disrupts the binding of Vpx to DCAF1, suggesting that Vpx uses the conserved helix domain for interaction with DCAF1 in a manner similar to Vpr [25,35].”
BackgroundThe SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis
Guo, H., Yang, W., Li, H., Yang, J., Huang, Y., Tang, Y., Wang, S., Ni, F., Yang, W., Yu, X., et al. (2024) · mBio · doi:10.1128/mbio.01363-24 · Cited by 14
“Subsequent studies have indicated that Vpx facilitates viral infection in macrophages by recruiting the CRL4(DCAF1) ubiquitin ligase complex and inducing the degradation of an unidentified antiviral factor (35, 36).”
BackgroundRestricted Access to Myeloid Cells Explained
Planelles, V. (2011) · Viruses · doi:10.3390/v3091624 · Cited by 14
“Two reports in 2008 demonstrated that the interaction of Vpx with DCAF1 is required for the enhancement of infectivity of myeloid cells [19,20].”
BackgroundBowen, N. E., Oo, A., & Kim, B. (2022) · Viruses · doi:10.3390/v14081622 · Cited by 14
Ciftci, H. I., Fujino, H., Koga, R., Yamamoto, M., Kawamura, S., Tateishi, H., Iwatani, Y., Otsuka, M., & Fujita, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.038 · Cited by 12
“Vpx is critical for reverse transcription of the viral RNA genome in macrophages [10,20] and dendritic cells of”
BackgroundLim, E. S., & Emerman, M. (2011) · Nature · doi:10.1038/474587a · Cited by 17
Virological characterization of HIV-2 vpx gene mutants in various cell systems
Nomaguchi, M., Doi, N., & Adachi, A. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.06.004 · Cited by 12
Species tropism of HIV-1 modulated by viral accessory proteins
Nomaguchi, M., Doi, N., Matsumoto, Y., Sakai, Y., Fujiwara, S., & Adachi, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00267 · Cited by 12
“In macrophages, ΔVpx replication is not detectable and this defect has been shown to be present at post-entry and before/during the reverse transcription process (Fujita et al., 2008, 2010; Srivastava et al., 2008).”
BackgroundPost-translational modifications inducing proteasomal degradation to counter HIV-1 infection
Proulx, J. M., Borgmann, K., & Park, I.-W. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198142 · Cited by 12
Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility
White, T. E., Brandariz-Núñez, A., Valle‐Casuso, J. C., Knowlton, C., Kim, B., Sawyer, S. L., & Diaz‐Griffero, F. (2014) · Virology · doi:10.1016/j.virol.2014.04.023 · Cited by 13
“The different human SAMHD1 polymorphisms were tested for their ability to block HIV-1, HIV-2 and equine infectious anemia virus (EIAV).”
BackgroundInfluentialMukai, R., & Ohshima, T. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00450-16 · Cited by 11
“Similarly, both the Vpr and Vpx proteins encoded by the human immunodeficiency virus (HIV) also interact with DDB1 (42, 43).”
BackgroundNomaguchi, M., Doi, N., Fujiwara, S., & Adachi, A. (2011) · InTech eBooks · doi:10.5772/23624 · Cited by 11
“Furthermore, a new restriction factor functional in macrophages and antagonized by Vpx has been proposed (Fujita et al., 2008; Fujita et al., 2010; Sharova et al., 2008; Srivastava et al., 2008).”
BackgroundRestriction of Retroviral Infection of Macrophages
Sharkey, M. E. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-37765-5_4 · Cited by 12
CRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
Dobransky, A., Root, M., Hafner, N., Marcum, M., & Sharifi, H. J. (2024) · Viruses · doi:10.3390/v16081313 · Cited by 13
“The most well-recognized phenotype of HIV-2 Vpx is its ability to markedly enhance infection of myeloid lineage macrophages and dendritic cells [193] through interactions with CRL4-DCAF1 [194–196].”
BackgroundUnderstanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx
Cassiday, P. A., DePaula-Silva, A. B., Chumley, J., Ward, J. P., Barker, E., & Planelles, V. (2014) · Virology · doi:10.1016/j.virol.2014.11.024 · Cited by 14
“Based on the high homology between their third α-helices, we favor a model in which HIV-1 Vpr and SIVmac Vpx utilize a similar, but not identical, binding interface on DCAF1 (Le Rouzic et al., 2007; Schwefel et al., 2014; Srivastava et al., 2008) (reviewed in Morellet et al. (2009)).”
InfluentialEsteva, M. J., Affranchino, J. L., & González, S. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114299 · Cited by 11
The Early Bird Catches the Worm - Can Evolution Teach us Lessons in Fighting HIV?
Schaller, T., & Herold, N. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224094914 · Cited by 8
The feasibility of incorporating Vpx into lentiviral gene therapy vectors
McAllery, S., Ahlenstiel, C., Suzuki, K., Symonds, G. P., Kelleher, A. D., & Turville, S. G. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.66 · Cited by 9
Coggins, S. A., Holler, J. M., Kimata, J. T., Kim, D., Schinazi, R. F., & Kim, B. (2019) · Virology · doi:10.1016/j.virol.2019.08.010 · Cited by 7
“Lentiviral Vpx directly binds to host SAMHD1 protein and induces the E3-ligase mediated proteasomal degradation of SAMHD1 (9,13,14).”
BackgroundWang, C., Zhang, K., Meng, L., Zhang, X., Song, Y., Zhang, Y., Gai, Y., Zhang, Y., Yu, B., Wu, J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012767 · Cited by 7
Hlavatý, J., Tonar, Z., Renner, M., Panitz, S., Petznek, H., Schweizer, M., Schüle, S., Kloke, B., Moldzio, R., & Witter, K. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1569-1 · Cited by 8
He, Y., Xu, M., Ouyang, J., Zhao, L., Ma, T., Zhang, X., Wang, R., Shang, H., & Liang, G. (2025) · Nature Communications · doi:10.1038/s41467-025-58218-2 · Cited by 6
McCulley, A., & Ratner, L. (2012) · Virology · doi:10.1016/j.virol.2012.02.002 · Cited by 7
Role of Innate Genes in HIV Replication
Schott, K., Rieß, M., & König, R. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_29 · Cited by 5
Zhang, N., Guo, H., Yang, J., Liu, G., Li, S., Li, S., Wang, D., Li, R., Shu, C., Xu, H., et al. (2017) · Virology · doi:10.1016/j.virol.2017.07.022 · Cited by 5
“The primary function of virion-associated Vpx is to promote the accumulation of viral DNA during reverse transcription (Fujita et al., 2008a; Goujon et al., 2007; Sharova et al., 2008; Srivastava et al., 2008).”
BackgroundYang, S., Zhou, Y., Zhan, Y., Yu, L., Jiang, Y., Tong, W., & Tong, G. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2014.0027 · Cited by 4
DCAF1 is involved in HCV replication through regulation of miR-122
Yan, Y., Li, C., Sun, B., & Yang, R. (2018) · Archives of Virology · doi:10.1007/s00705-017-3691-8 · Cited by 5
SIVSM/HIV-2 Vpx Proteins: Function and Uses in the Infection of Primary Myeloid Cells
Berger, G., & Cimarelli, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-670-2_13 · Cited by 4
Role of poly-proline motif in HIV-2 Vpx expression
Miyake, A., Miyazaki, Y., Fujita, M., Nomaguchi, M., & Adachi, A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00024 · Cited by 4
“OPINION ARTICLE published: 28 January 2014 doi: 10.3389/fmicb.2014.00024 Role of poly-proline motif in HIV-2 Vpx expression”
BackgroundResultInfluentialCoggins, S. A., Kim, D., Schinazi, R. F., Desrosier, R. C., & Kim, B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015273 · Cited by 4
Role of Intracellular Distribution of Feline and Bovine SAMHD1 Proteins in Lentiviral Restriction
Wang, C., Meng, L., Wang, J., Zhang, K., Duan, S., Ren, P., Wei, Y., Fu, X., Yu, B., Wu, J., et al. (2021) · Virologica Sinica · doi:10.1007/s12250-021-00351-5 · Cited by 4
Nguyen, X.-N., Barateau, V., Wu, N., Berger, G., & Cimarelli, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140561 · Cited by 4
“The infection of myeloid cells by primate lentiviruses is however hindered by a strong restriction that limits vDNA accumulation during the early phases of the viral life cycle [5,6,7,8,9,10,11,12,13,14,15].”
BackgroundLarrous, P., Garnier, C., Morel, M., Martin, M. M., Zarrouk, K., Maesen, S., Matkovic, R., Cimarelli, A., Etienne, L., & Margottin-Goguet, F. (2025) · Journal of Virology · doi:10.1128/jvi.00198-25 · Cited by 4
Retroviral Factors Promoting Infectivity
Cuccurullo, E. C., Valentini, C., & Pizzato, M. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.008 · Cited by 4
Lentiviral Vpx induces alteration of mammalian cell nuclear envelope integrity
Singh, S. P., Raja, S., & Mahalingam, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.018 · Cited by 3
Münch, J., & Kirchhoff, F. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00001-0 · Cited by 3
Host cell-specific effects of lentiviral accessory proteins on the eukaryotic cell cycle progression
Matsuda, M., Arai, A., Nakamura, Y., Fujisawa, R., & Masuda, M. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.03.006 · Cited by 3
Study on Molecular Function of Proteins of Human Immunodeficiency Virus
Fujita, M. (2013) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.13-00200 · Cited by 2
The Fourth Major Restriction Factor Against HIV/SIV
Nomaguchi, M., Fujita, M., & Adachi, A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00132 · Cited by 2
“…thought to be critical for the nuclear import of viral DNA in non-dividing cells until we and others have independently and clearly demonstrated that it is essential for the reverse transcription of viral RNA in MDDCs (Goujon et al., 2007) and MDMs (Fujita et al., 2008; Srivastava et al., 2008).”
BackgroundGoujon, C., Darlix, J. L., & Cimarelli, A. (2009) · PubMed · doi:10.1684/vir.2009.0268 · Cited by 2
“En effet, une étude évoque une interaction directe entre Vpx et DDB1 [34], suggérant que Vpx a la capacité de contacter directement le complexe sans l’adaptateur DCAF1.”
BackgroundInfluentialHD domain of SAMHD1 influences Vpx-induced degradation at a post-interaction step
Kang, J., Hou, J., Zhao, K., Yu, X.-F., & Du, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.080 · Cited by 2
Multifunctional HIV accessory proteins are hub proteins antagonizing host antiviral factors
Kitamura, S., & Iwatani, Y. (2013) · Uirusu · doi:10.2222/jsv.63.187 · Cited by 2
Nair, R., Pignot, Y. L., Salinas-Illarena, A., Bärreiter, V. A., Wratil, P. R., Keppler, O. T., Wichmann, C. W., & Baldauf, H. (2023) · Analytical Biochemistry · doi:10.1016/j.ab.2023.115153 · Cited by 2
HIV-1 Vpr and G2 Cell Cycle Arrest
Nomaguchi, M., & Adachi, A. (2011) · Future Microbiology · doi:10.2217/fmb.11.17 · Cited by 1
De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells
Enya, B., & Skowroński, J. (2025) · Viruses · doi:10.3390/v17070958 · Cited by 1
“The supernatant containing HIV-1 particles was treated with 40 units/mL DNase I (MilliporeSigma, Burlington, MA, USA) for 1 h at 27 ◦ C, sterile filtered (MilliporeSigma), and the virus concentrated by pelleting through a 20% sucrose cushion, as previously described [47].”
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes
Colomer-Lluch, M., Castro‐Gonzalez, S., & Serra-Moreno, R. (2019) · Caister Academic Press eBooks · doi:10.21775/9781912530120.24 · Cited by 1
Accessory proteins of HIV and innate anti-retroviral factors
Nomaguchi, M., & Adachi, A. (2009) · Uirusu · doi:10.2222/jsv.59.67 · Cited by 1
Gama, L. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-22092011-115312
Identification of the Function of the Vpx Protein of Primate Lentiviruses: A Dissertation
Zhu, X. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/cgm8-q756
Ruiz, A. J. (2010) · KU ScholarWorks (University of Kansas)
Host Cell Factors in HIV-1 Replication Cycle
Boso, G. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)
Hepatitis B Virus and Hepatocellular Carcinogenesis
Yen, T. S. B. (2009) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812833471_0002
McAllery, S. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Khan, K. A. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
HIV-1 Evasion of Human TRIM5α via Cyclophilin A
Kim, K. (2020) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hptw-yg49
Resistance to human immunodeficiency virus infection: a rare but neglected state
Tamalet, C., Devaux, C. A., Dubourg, G., & Colson, P. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14452 · Cited by 2
Curlin, J., Akkina, R., Aboellail, T., Stenglein, M., & Wiese, C. (2020) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.04610
The KT Jeang Retrovirology prize 2022: Florence Margottin-Goguet
Editorial, R. (2022) · Retrovirology · doi:10.1186/s12977-022-00606-3
Metadata
- Authors
- Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Stowers Institute for Medical Research (US)
- New York University (US)
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-05-09
- Volume
- 4
- Issue
- 5
- Pages
- e1000059
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2330158
- OpenAlex
- W2068349374
- Cited by
- 209
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 7 · 2019: 14 · 2018: 7 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 24 · 2013: 24 · 2012: 29
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Allergy and Infectious Diseases (AI-77459, AI 42561, AI033303, R37AI033303, R01AI077459, R01AI042561)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- Vpx, VprBP, DCAF1, DDB1, HIV-2, reverse transcription, ubiquitin-proteasome system, monocyte-derived cells
- MeSH terms
- Animals, Cell Line, Fluoresceins, Humans, Leukocytes, Mononuclear, Macrophages, Simian Immunodeficiency Virus, Signal Transduction, CD4-Positive T-Lymphocytes, Gene Expression Regulation, Viral, Macrophage Colony-Stimulating Factor, Gene Products, vpr, Ubiquitin-Protein Ligases, Cullin Proteins, Adaptor Proteins, Signal Transducing, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.